Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates

Heather Bean, Christiaan A. Rees, Jane E. Hill

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    Pseudomonas aeruginosa is a nearly ubiquitous Gram-negative organism, well known to occupy a multitude of environmental niches and cause human infections at a variety of bodily sites, due to its metabolic flexibility, secondary to extensive genetic heterogeneity at the species level. Because of its dynamic metabolism and clinical importance, we sought to perform a comparative analysis on the volatile metabolome (the 'volatilome') produced by P. aeruginosa clinical isolates. In this study, we analyzed the headspace volatile molecules of 24 P. aeruginosa clinical isolates grown in vitro, using 2D gas chromatography time-of-flight mass spectrometry (GCGC-TOFMS). We identified 391 non-redundant compounds that we associate with the growth and metabolism of P. aeruginosa (the 'pan-volatilome'). Of these, 70 were produced by all 24 isolates (the 'core volatilome'), 52 by only a single isolate, and the remaining 269 volatile molecules by a subset. Sixty-five of the detected compounds could be assigned putative compound identifications, of which 43 had not previously been associated with P. aeruginosa. Using the accessory volatile molecules, we determined the inter-strain variation in the metabolomes of these isolates, clustering strains by their metabotypes. Assessing the extent of metabolomic diversity in P. aeruginosa through an analysis of the volatile molecules that it produces is a critical next step in the identification of novel diagnostic or prognostic biomarkers.

    Original languageEnglish (US)
    Article number047102
    JournalJournal of Breath Research
    Volume10
    Issue number4
    DOIs
    StatePublished - Nov 21 2016

    Fingerprint

    Metabolome
    Pseudomonas aeruginosa
    Metabolomics
    Genetic Heterogeneity
    Gas Chromatography
    Cluster Analysis
    Mass Spectrometry
    Biomarkers
    Growth
    Infection

    Keywords

    • bacterial infections, biomarkers
    • comparative metabolomics
    • GC × GC-TOFMS
    • Pseudomonas aeruginosa

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine

    Cite this

    Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates. / Bean, Heather; Rees, Christiaan A.; Hill, Jane E.

    In: Journal of Breath Research, Vol. 10, No. 4, 047102, 21.11.2016.

    Research output: Contribution to journalArticle

    @article{35a5ca1832c445e0bd911a0c5e905e47,
    title = "Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates",
    abstract = "Pseudomonas aeruginosa is a nearly ubiquitous Gram-negative organism, well known to occupy a multitude of environmental niches and cause human infections at a variety of bodily sites, due to its metabolic flexibility, secondary to extensive genetic heterogeneity at the species level. Because of its dynamic metabolism and clinical importance, we sought to perform a comparative analysis on the volatile metabolome (the 'volatilome') produced by P. aeruginosa clinical isolates. In this study, we analyzed the headspace volatile molecules of 24 P. aeruginosa clinical isolates grown in vitro, using 2D gas chromatography time-of-flight mass spectrometry (GCGC-TOFMS). We identified 391 non-redundant compounds that we associate with the growth and metabolism of P. aeruginosa (the 'pan-volatilome'). Of these, 70 were produced by all 24 isolates (the 'core volatilome'), 52 by only a single isolate, and the remaining 269 volatile molecules by a subset. Sixty-five of the detected compounds could be assigned putative compound identifications, of which 43 had not previously been associated with P. aeruginosa. Using the accessory volatile molecules, we determined the inter-strain variation in the metabolomes of these isolates, clustering strains by their metabotypes. Assessing the extent of metabolomic diversity in P. aeruginosa through an analysis of the volatile molecules that it produces is a critical next step in the identification of novel diagnostic or prognostic biomarkers.",
    keywords = "bacterial infections, biomarkers, comparative metabolomics, GC × GC-TOFMS, Pseudomonas aeruginosa",
    author = "Heather Bean and Rees, {Christiaan A.} and Hill, {Jane E.}",
    year = "2016",
    month = "11",
    day = "21",
    doi = "10.1088/1752-7155/10/4/047102",
    language = "English (US)",
    volume = "10",
    journal = "Journal of Breath Research",
    issn = "1752-7155",
    publisher = "IOP Publishing Ltd.",
    number = "4",

    }

    TY - JOUR

    T1 - Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates

    AU - Bean, Heather

    AU - Rees, Christiaan A.

    AU - Hill, Jane E.

    PY - 2016/11/21

    Y1 - 2016/11/21

    N2 - Pseudomonas aeruginosa is a nearly ubiquitous Gram-negative organism, well known to occupy a multitude of environmental niches and cause human infections at a variety of bodily sites, due to its metabolic flexibility, secondary to extensive genetic heterogeneity at the species level. Because of its dynamic metabolism and clinical importance, we sought to perform a comparative analysis on the volatile metabolome (the 'volatilome') produced by P. aeruginosa clinical isolates. In this study, we analyzed the headspace volatile molecules of 24 P. aeruginosa clinical isolates grown in vitro, using 2D gas chromatography time-of-flight mass spectrometry (GCGC-TOFMS). We identified 391 non-redundant compounds that we associate with the growth and metabolism of P. aeruginosa (the 'pan-volatilome'). Of these, 70 were produced by all 24 isolates (the 'core volatilome'), 52 by only a single isolate, and the remaining 269 volatile molecules by a subset. Sixty-five of the detected compounds could be assigned putative compound identifications, of which 43 had not previously been associated with P. aeruginosa. Using the accessory volatile molecules, we determined the inter-strain variation in the metabolomes of these isolates, clustering strains by their metabotypes. Assessing the extent of metabolomic diversity in P. aeruginosa through an analysis of the volatile molecules that it produces is a critical next step in the identification of novel diagnostic or prognostic biomarkers.

    AB - Pseudomonas aeruginosa is a nearly ubiquitous Gram-negative organism, well known to occupy a multitude of environmental niches and cause human infections at a variety of bodily sites, due to its metabolic flexibility, secondary to extensive genetic heterogeneity at the species level. Because of its dynamic metabolism and clinical importance, we sought to perform a comparative analysis on the volatile metabolome (the 'volatilome') produced by P. aeruginosa clinical isolates. In this study, we analyzed the headspace volatile molecules of 24 P. aeruginosa clinical isolates grown in vitro, using 2D gas chromatography time-of-flight mass spectrometry (GCGC-TOFMS). We identified 391 non-redundant compounds that we associate with the growth and metabolism of P. aeruginosa (the 'pan-volatilome'). Of these, 70 were produced by all 24 isolates (the 'core volatilome'), 52 by only a single isolate, and the remaining 269 volatile molecules by a subset. Sixty-five of the detected compounds could be assigned putative compound identifications, of which 43 had not previously been associated with P. aeruginosa. Using the accessory volatile molecules, we determined the inter-strain variation in the metabolomes of these isolates, clustering strains by their metabotypes. Assessing the extent of metabolomic diversity in P. aeruginosa through an analysis of the volatile molecules that it produces is a critical next step in the identification of novel diagnostic or prognostic biomarkers.

    KW - bacterial infections, biomarkers

    KW - comparative metabolomics

    KW - GC × GC-TOFMS

    KW - Pseudomonas aeruginosa

    UR - http://www.scopus.com/inward/record.url?scp=85008223104&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85008223104&partnerID=8YFLogxK

    U2 - 10.1088/1752-7155/10/4/047102

    DO - 10.1088/1752-7155/10/4/047102

    M3 - Article

    VL - 10

    JO - Journal of Breath Research

    JF - Journal of Breath Research

    SN - 1752-7155

    IS - 4

    M1 - 047102

    ER -